2-211705339-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_005235.3(ERBB4):c.1177C>A(p.Arg393=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000218 in 1,612,040 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00035 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 1 hom. )
Consequence
ERBB4
NM_005235.3 synonymous
NM_005235.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.79
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 2-211705339-G-T is Benign according to our data. Variant chr2-211705339-G-T is described in ClinVar as [Benign]. Clinvar id is 732285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000355 (54/152236) while in subpopulation EAS AF= 0.00906 (47/5188). AF 95% confidence interval is 0.007. There are 1 homozygotes in gnomad4. There are 34 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 54 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERBB4 | NM_005235.3 | c.1177C>A | p.Arg393= | synonymous_variant | 10/28 | ENST00000342788.9 | NP_005226.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERBB4 | ENST00000342788.9 | c.1177C>A | p.Arg393= | synonymous_variant | 10/28 | 1 | NM_005235.3 | ENSP00000342235 | P4 | |
ERBB4 | ENST00000436443.5 | c.1177C>A | p.Arg393= | synonymous_variant | 10/27 | 1 | ENSP00000403204 | A1 | ||
ERBB4 | ENST00000484594.5 | n.1229C>A | non_coding_transcript_exon_variant | 10/20 | 1 | |||||
ERBB4 | ENST00000260943.11 | c.1177C>A | p.Arg393= | synonymous_variant | 10/27 | 5 | ENSP00000260943 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152118Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
54
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000636 AC: 160AN: 251486Hom.: 0 AF XY: 0.000611 AC XY: 83AN XY: 135916
GnomAD3 exomes
AF:
AC:
160
AN:
251486
Hom.:
AF XY:
AC XY:
83
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000204 AC: 298AN: 1459804Hom.: 1 Cov.: 29 AF XY: 0.000198 AC XY: 144AN XY: 726428
GnomAD4 exome
AF:
AC:
298
AN:
1459804
Hom.:
Cov.:
29
AF XY:
AC XY:
144
AN XY:
726428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000355 AC: 54AN: 152236Hom.: 1 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74406
GnomAD4 genome
AF:
AC:
54
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
34
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at